India Approves First Dengue Vaccine for Market Release
India's drug regulator, DCGI, has approved the first dengue vaccine, which is expected to be available in the market next year.
4 stories found
India's drug regulator, DCGI, has approved the first dengue vaccine, which is expected to be available in the market next year.
The agency is under pressure to tighten oversight of the $42 billion pharma industry, dominated by small manufacturers, after India-made cough syrups have been tied to the deaths of more than 140 children in Africa and Central Asia since 2022, denting its reputation as the “pharmacy of the world”
India has approved its first dengue vaccine, Qdenga by Takeda, for individuals aged 4 to 60, following clearance from the DCGI. This marks a significant step in the country's efforts to combat dengue fever.